Long DARE signal by Rajiv Menon

DARE looks LONG now Observation: the stock got a nice jolt after the positive Ovaprene update and the Q1 numbers, so this is not random noise, it has a reason behind it. Macro view: when a tiny biotech gets real trial progress plus fresh company update, money can stick around for a bit if sellers are not too nasty. Principle: market loves to overreact, but the clean news flow is still on the buy side here; no need to make a big tragic movie out of one sharp pullback. Measured conclusion: I’d sta